SCHEMBL5873654

SCHEMBL5873654

COC(=O)c1cc(N2CC3CCC2C3)nc2ccc(N)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHMT2 P34897 2/20 0.44
KDM4E B2RXH2 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 2/20 0.41
USP2 O75604 1/20 0.41
PKM P14618 1/20 0.41
MAP3K12 Q12852 3/20 0.39
MCHR1 Q99705 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
PLA2G2A P14555 5/20 0.36
GAA P10253 1/20 0.36
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
HTR3A P46098 1/20 0.36
HTR3D Q70Z44 1/20 0.36
HTR3C Q8WXA8 1/20 0.36
OPRK1 P41145 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5873483 0.84 ALDH1A1 (0.43) KDM4EMEN1KMT2AALDH1A1USP2
SCHEMBL5873653 0.75 MCHR1 (0.73) MCHR1
SCHEMBL11894679 0.70 KDM4E (0.68) KDM4EALDH1A1L3MBTL1NPC1PLA2G2A
SCHEMBL20897480 0.65 ALDH1A1 (0.51) KDM4EMEN1KMT2AALDH1A1PKM
SCHEMBL15919505 0.65 EPRS1 (0.75) KDM4EMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL22492354 0.65 KDM4E (0.54) KDM4EMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL20897529 0.64 ALDH1A1 (0.47) KDM4EALDH1A1USP2PKMNPC1
Hydrochloric Acid SCHEMBL32685626 0.64 KDM4E (0.52) KDM4EMEN1KMT2AALDH1A1L3MBTL1
Hydrochloric Acid SCHEMBL31139660 0.64 KDM4E (0.52) KDM4EMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL24532587 0.63 CYP2D6 (0.37) KDM4EMEN1KMT2AMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7084156-B2 2-Aminoquinoline compounds MERCK & CO., INC. (US) 2006-08-01 US disclosed
US-20050026915-A1 2-Aminoquinoline compounds MERCK SHARP & DOHME CORP. 2005-02-03 US disclosed
EP-1450801-A2 2-AMINOQUINOLINE COMPOUNDS Merck & Co., Inc. (US) 2004-09-01 EP disclosed
WO-2003045313-A2 2-AMINOQUINOLINE COMPOUNDS MERCK & CO. INC. (US) 2003-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026915-A1 2-Aminoquinoline compounds MCHR1, MCHR2, MC5R SHMT2 267/4885KDM4E 822/4885MEN1 509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.